Tirzepatide's dual mechanism targets GIP and GLP-1, so it provides strong cardiovascular benefits, said Stephen Nicholls, ...

Adela Kim ’26 combined an MBA and a PhD in history of art in order to deepen her research and prepare for a career managing ...

Vallerie McLaughlin, MD, the Kim A. Eagle M.D. Endowed Professor of Cardiovascular Medicine and professor of internal medicine at the University of Michigan Medical School, highlighted the need for ...

Dr. Andreas Wallnöfer joins Optigo Biotherapeutics' Board, bringing expertise from Jeito Capital, BioMedPartners, and Roche.

I work with high-functioning professionals whose stressful lives are causing relationship issues, depression, or anxiety. I have a passion for helping organizational leaders better manage their ...

David Apelian MD PhD MBA, an experienced CEO with significant development and regulatory experience in virology and immune-oncology, joins Theolytics Dr Apelian joins as the company advances its first ...

Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use. Clinical Advisor, a trusted source of medical news and feature ...

After wrapping up their undergraduate careers, these hospital CEOs continued along the path of education to achieve a broad spectrum of professional expertise. Doctor of Philosophy degree in business ...

Dr. John Lee is the global head of cell and gene therapy at SK pharmteco, and a leader in the field of cell and gene therapy. With more than 25 years of expertise, he has a proven track record in ...

Reports Q3 revenue $14.34M, consensus $9.75M. “In the third quarter, Verrica achieved multiple commercial, corporate, scientific and regulatory ...

Nivolumab plus ipilimumab provides lasting benefits over sunitinib in patients with advanced renal cell carcinoma, according to an 8-year update of the phase 3 CheckMate 214 trial. Oncologists’ ...